Phase I Studies

Dedicated Phase I Unit with Extensive First-in-Human and BA/BE Study Experience Our fully-equipped Phase I unit is an ideal solution for conducting both healthy volunteer and patient population trials. Our Phase I unit provides a comfortable and safe environment for study participants, who are monitored and supervised by our certified investigators and experienced study team. We offer successful Phase I experience across numerous therapeutic areas and experience in both First-in-Human and BA/BE studies. …learn more

In-Hospital Trials

Integrated into 5 Leading Hospitals in the Southeast; Credentialed Staff of Nurses and PAs Achieve the best of both worlds: working with a dedicated clinical trial company that delivers full integration into major hospitals. Embedded in 5 leading hospitals in the Southeast, we provide the ideal setting for conducting surgical and other inpatient studies. Accel provides access to a wide range of specialists, strong patient volume from our physician network, and a highly experienced, hospital credentialed staff for efficient recruitment, regulatory oversight and on-site management of your studies. …learn more

Phase II-IV Studies

Successful Experience with the Top 20 Global Pharmaceutical Companies With the successful execution of nearly 1,000 trials, Accel has a proven track record of delivering quality on a foundation of strong recruitment and rapid implementation. Nowhere is this more necessary than in outpatient trials. A key strength lies in our ability to recruit and enroll qualified subjects rapidly and efficiently. Surrounded by retirement communities and colleges, our site locations are demographically diverse and conveniently accessible to subjects, enabling fast enrollment for many indications. …learn more

Vaccine Trials

Multi-Therapeutic Sites with Unique and Highly Effective Trial Capabilities and Expertise Our proficient and experienced team members engage quickly and provide strategic thinking to execute on vaccine trials. This ensures faster start-up times and efficient delivery on every vaccine study. …learn more